Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

How to Get Pharma Leaders to Wrap Their Minds—and Their Arms—Around Advanced Analytics

Posted by Shreyas Murthi on Mon, Mar 11, 2019

 

The business of pharma is becoming more data-driven—from R&D to commercial—yet many pharma companies still struggle to garner leaders’ buy-in to build and operate the analytics programs that they need to fuel their success. They face tough challenges, including overcoming skepticism, proving the program’s value and scalability, finding the right talent and ensuring organizational collaboration.    

Read More

Topics: predictive analytics, Analytics, pharmaceuticals, change management, data analytics, pharma companies, artificial intelligence & pharma, cutting-edge analytics, technology investment, advanced analytics, personalized analytics, analytics maturity

The Death of Dashboards, and the Promise of Personalized Analytics

Posted by ZS Editors on Mon, Jan 07, 2019

Multiple factors are colliding to encourage the need for personalized analytics. The ever-expanding explosion of data is forcing companies to consider more nimble, automated solutions that simplify the user experience. The need for competitive advantage in a crowded marketplace is inspiring companies to arm reps with sales tools that give them an edge. Reps are increasingly expecting the kind of user experience that they get from consumer applications. The list goes on.

Personalization conjures a future where reps are no longer bombarded with information and expected to draw their own insights. In this future, AI-driven insights come to them as alerts on their mobile devices, personalized to their needs and customers, and delivered at the best possible time. 

But this is pharma. Surely the spreadsheets and dashboards will persist, right?

Read More

Topics: artificial intelligence, analytics disruption, commercial analytics, artificial intelligence & pharma, cutting-edge analytics, advanced analytics, personalized analytics, analytics maturity, data and insights

Making the Case for a New Analytics Consumption Model

Posted by ZS Editors on Thu, Nov 29, 2018

Industries like retail and technology are transitioning to an AI-driven, personalized approach to surfacing insights to end users, and they’re reaping the benefits. Life sciences companies have the same opportunity to capitalize on the runaway growth in data and rethink the way that analytics are consumed.  

ZS recently partnered with IDC to study how commercial life sciences teams are currently consuming data, and to determine their data and analytics pain points. The study revealed that sales and marketing professionals in life sciences want

Read More

Topics: Analytics, artificial intelligence, AI, data and analytics, analytics disruption, commercial analytics, artificial intelligence & pharma, cutting-edge analytics, advanced analytics, personalized analytics, analytics maturity, pharma commercial model

How Do Doctors Feel About Robots in the Exam Room?

Posted by Paul Darling on Wed, Aug 29, 2018

This blog post is the first in a series on ZS’s 2018 AI in Healthcare study.

Data-rich, technology-based solutions like artificial intelligence are lining up to transform many facets of healthcare, but before we start planning for the transformation that this technology can bring, we might want to do a reality check: Will AI truly be disruptive in an industry that has been slow to adopt new technologies, or will the change be incremental? And even if AI can improve care delivery, what do doctors—and patients—think about inviting AI into the exam room?

Read More

Topics: physician, Paul Darling, artificial intelligence, automation tools, artificial intelligence & pharma, care delivery, data-driven care, healthcare administrative tasks, AI in Healthcare study

New ZS Research on Forecasting in an Evolving Landscape

Posted by Ram Ramakrishnan on Mon, Jul 09, 2018

This post is the second in a four-part series on how pharmaceutical companies can elevate their forecasting operations.

The pharmaceutical industry is facing an increasingly challenging environment with looming biosimilar launches, tighter access and pricing controls, and saturation within primary care markets. Forecasting as a functional area is affected by these changes, given the range of decisions that forecasts inform.

Read More

Topics: forecasting, Pharma, insights, artificial intelligence, AI, machine learning, artificial intelligence & pharma, pharma landscape, ZS research, forecasting in pharma

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×